Halofenate, serum lipids, and exercise performance in coronary heart disease.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000097:blood / Q000503:physiopathology; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000503:physiopathology*; D005260:Female; D006016:Glycolates / Q000494:pharmacology*; D006218:Halofenate / Q000494:pharmacology; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000503:physiopathology; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D006016:Glycolates; D000960:Hypolipidemic Agents; D008055:Lipids; D014280:Triglycerides; D002784:Cholesterol; D006218:Halofenate